🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthew J. Jackson

Merz (United States)

ORCID: 0000-0001-5392-845X
Economics, Econometrics and FinanceMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Foundational research and NIH funding enabling Emergency Use Authorization of remdesivir for COVID-19.

11 citations

Matthew J. Jackson, Zoë Folchman-Wagner, Fred D. Ledley, Ekaterina Galkina Cleary

2 citations

Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley, Anthony E. Kiszewski

38 citations

Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley, Anthony E. Kiszewski

N/A
0DataRank · unranked
15 citations

Matthew J. Jackson, Peter H. Smith, Katharina Hopp, Michel Chonchol, Berenice Y. Gitomer +4 more

57 citations

Matthew J. Jackson, Edward W. Zhou, Fred D. Ledley, Ekaterina Galkina Cleary

27 citations

Matthew J. Jackson, Fred D. Ledley, Edward Zhou